No Data
No Data
Huadong Medicine (000963.SZ): The company has now established an ai-assisted drug development (AIDD) platform.
Gelonghui November 14th | Huadong Medicine (000963.SZ) stated on the investor interaction platform that the company has now established an ai-assisted drug research and development (AIDD) platform, with the main purpose of providing intelligent assistance tools for innovative drug research and development, improving research and development efficiency, and reducing research and development costs. Currently, this business has a relatively small overall impact on the company, please investors to pay attention to the risks and invest rationally.
An Intrinsic Calculation For Huadong Medicine Co., Ltd (SZSE:000963) Suggests It's 50% Undervalued
Huadong Medicine Gets Drug Registration for Plaque Psoriasis Treatment Drug; Shares Up 3%
huadong medicine (000963.SZ): Wholly-owned subsidiary Wusinu Monoclonal Antibody Injection obtained pharmaceutical registration certificate
On November 5th, Gelunhui reported that Huadong Medicine (000963.SZ) announced that on November 5, 2024, its wholly-owned subsidiary Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd. (hereinafter referred to as "Zhongmei Huadong") received the "Pharmaceutical Registration Certificate" issued by the National Medical Products Administration (NMPA) for the approved marketing application of Ustekinumab Injection (Selexin) (research and development code: HDM3001/QX001S) applied by Zhongmei Huadong, which is used to treat moderate to severe plaque psoriasis in adults. Upon investigation, Selexin is the first domestically approved Ustekinumab injection biosimilar.
huadong medicine (000963.SZ): did not cooperate with novo-nordisk a/s on semaglutide products.
Gelonghui October 31st | Huadong Medicine (000963.SZ) stated on the investor interaction platform that the company is currently not cooperating with novo-nordisk a/s on semaglutide products.
Earnings Report: Huadong Medicine Co., Ltd Missed Revenue Estimates By 5.3%
No Data
No Data